Ligand Pharmaceuticals Incorporated (FRA:LGDN)

Ligand Pharmaceuticals Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 29, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	3,182	1,956	1,127	1,056	2,270	1,307
Market Cap Growth	57.14%	73.58%	6.69%	-53.48%	73.60%	-19.90%
Enterprise Value	3,003	1,751	960	1,049	2,276	1,033
Last Close Price	160.00	104.00	64.50	62.76	93.89	52.59
PE Ratio	76.86	-	23.88	-	45.18	-
PS Ratio	14.86	12.11	9.48	5.75	10.69	9.78
PB Ratio	3.93	2.44	1.78	1.89	3.14	2.25
P/TBV Ratio	6.07	4.42	4.18	8.11	7.85	-
P/FCF Ratio	121.39	21.26	27.04	8.99	36.86	31.90
P/OCF Ratio	116.99	20.86	25.12	8.19	32.76	29.30
EV/Sales Ratio	14.20	10.84	8.08	5.71	10.72	7.73
EV/EBITDA Ratio	62.34	31.11	22.90	27.11	22.09	18.31
EV/EBIT Ratio	163.57	78.73	108.04	369.11	39.07	30.77
EV/FCF Ratio	114.53	19.03	23.04	8.93	36.96	25.22
Debt / Equity Ratio	0.48	0.01	0.01	0.15	0.40	0.64
Debt / EBITDA Ratio	7.02	0.12	0.13	2.09	2.74	6.42
Debt / FCF Ratio	14.66	0.08	0.13	0.70	4.63	9.11
Asset Turnover	0.21	0.19	0.17	0.19	0.18	0.11
Inventory Turnover	6.74	1.71	1.88	4.38	3.50	4.20
Quick Ratio	23.66	8.05	12.49	2.50	10.39	4.70
Current Ratio	24.69	8.93	14.15	2.67	11.15	5.00
Return on Equity (ROE)	5.42%	-0.53%	8.29%	-0.74%	9.98%	0.89%
Return on Assets (ROA)	1.48%	1.66%	0.79%	0.18%	3.11%	1.80%
Return on Invested Capital (ROIC)	3.36%	-6.59%	1.64%	-0.07%	8.50%	7.45%
Return on Capital Employed (ROCE)	2.00%	2.50%	1.30%	0.50%	5.30%	3.30%
Earnings Yield	1.30%	-0.20%	4.19%	-2.96%	2.21%	-0.19%
FCF Yield	0.82%	4.70%	3.70%	11.12%	2.71%	3.13%
Buyback Yield / Dilution	-6.20%	-3.00%	-5.27%	2.19%	-2.50%	14.84%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.